NovaCell Institute has been delivering high-quality regenerative stem cell therapy to patients for over 25 years. From neurological conditions to sports injuries and chronic disease, we have witnessed meaningful improvements in patients who once felt they had limited options.
In this article, we answer the question “How much does stem cell therapy cost?” and explain what sets NovaCell Institute apart as a leader in advanced regenerative medicine worldwide.
At NovaCell Barranquilla, treatment begins at $13,900 USD for children and $24,900 USD for adults. Each program is designed with a focus on safety, precision, and clinical excellence in regenerative medicine. Patients receive care from an experienced medical team dedicated to delivering advanced stem cell therapy in a professional, patient-centered environment in the heart of Barranquilla.
NovaCell Institute, founded by Hakan Altunbas in collaboration with leading scientists and doctors in the field of “Regenerative Medicine”, is committed to delivering evidence-informed stem cell therapy with a focus on safety, quality, and clinical integrity. Built on internationally recognized research in mesenchymal stem cell science, NovaCell Institute’s treatment protocols reflect years of progress in the field of regenerative biotechnology and are designed to support consistent, patient-centered care in a professional clinical setting in Barranquilla.
What sets NovaCell Institute apart is that it is more than a medical clinic.
Built as part of an integrated regenerative medicine approach, NovaCell Institute combines clinical application with ongoing scientific collaboration in the field of stem cell research. The organization is committed to working alongside leading international partners to stay aligned with the latest developments in regenerative science, ensuring that every treatment is guided by evolving evidence, safety standards, and clinical innovation.
Our mesenchymal stem cells (MSCs) are derived from donated umbilical cords collected after healthy, full-term births. At NovatCell Institute, every donation undergoes strict screening, testing, and sterile processing protocols to ensure the highest standards of quality, safety, and consistency.
This carefully controlled process supports the development of a high-quality cellular product used in regenerative medicine protocols for conditions such as multiple sclerosis (MS) and other immune-related and degenerative disorders.
These cells are known for helping the body:
Mesenchymal stem cells (MSCs), also referred to as ‘medicinal signaling cells,’ are known for their ability to communicate with surrounding tissues through the release of bioactive signals. This cellular communication plays a key role in modulating immune responses and supporting the body’s natural repair processes. Another important characteristic is that MSCs are typically low in immunogenicity, meaning they are less likely to be recognized as foreign by the recipient’s immune system, which supports their use in allogeneic regenerative medicine applications.
This low immunogenic profile supports their compatibility in allogeneic applications and makes mesenchymal stem cells a strong foundation for advanced cell-based therapies. At NovaCell Institute, these principles guide the development of our regenerative medicine protocols, where cellular quality, safety, and scientific rigor are prioritized at every stage. Our commitment to research-driven standards and laboratory excellence is designed to support optimal therapeutic potential and consistent clinical outcomes in stem cell therapy.
For over 25 years, the field of regenerative medicine has evolved through continuous research and clinical experience across multiple cellular sources, including cord blood, bone marrow, and adipose-derived cells, ultimately advancing toward mesenchymal stem cells (MSCs) as a key focus in modern applications. At NovaCell, this foundation of scientific progress and innovation guides our approach to regenerative therapy, with an ongoing commitment to improving cell quality, safety, and consistency in clinical use..
These specialized cell preparations were developed through research conducted in collaboration with our laboratory partner, InnoCell, NovaCell Institute’s supplier lab. The process began after clinicians observed that certain patients demonstrated outcomes that appeared more favorable than expected in comparable cases. This led to a structured retrospective analysis over approximately two and a half years, aimed at better understanding the variables associated with these differences in response.
Through this ongoing work, the goal has been to refine cell processing standards and further improve consistency, quality, and clinical application in regenerative medicine protocols.”**
Internal observational analyses of clinical outcomes were conducted to evaluate variability in patient responses to stem cell–based therapies. Cases demonstrating comparatively favorable outcomes were retrospectively reviewed, with attention given to differences in cell processing parameters, manufacturing conditions, and administration protocols.
This exploratory assessment incorporated comparative evaluation of multiple cellular preparations and associated laboratory variables over time, with the objective of identifying potential correlates of therapeutic response.
Findings from this ongoing quality and process review have informed iterative refinements in laboratory protocols at NovaCell Institute and its supplier laboratory, InnoCell. The overarching aim of this work is to improve standardization, reproducibility, and product consistency within regenerative medicine applications.
As. Dr. Castro Explains:
“Recent efforts in regenerative medicine have increasingly focused on understanding heterogeneity among mesenchymal stem cell (MSC) preparations and how manufacturing and processing variables may influence biological performance and clinical outcomes.
From a clinical research perspective, MSCs are not a uniform product; rather, they represent a biologically diverse population whose characteristics may vary depending on donor factors, processing methods, and expansion conditions. This variability has prompted growing interest in retrospective analyses of clinical datasets to explore potential correlations between specific cell attributes and observed patient outcomes.
At NovaCell Institute and its supplier laboratory, InnoCell, ongoing observational data review is being used as part of a broader effort to refine cell selection criteria and improve consistency in therapeutic applications for patients with chronic and degenerative conditions. The goal of this work is not to oversimplify MSCs as identical products, but to better understand their biological variability and optimize their clinical utility through evidence-informed refinement of laboratory processes.”
Are you ready to begin your stem cell treatment journey? Apply today!
Stem cell therapy at NovaCell Institute in Barranquilla ranges from $13,900 to $24,900, depending on whether the patient is a child or an adult.
More than a clinic, NovaCell Institute is part of an evolving field in regenerative medicine focused on clinical application, laboratory quality, and ongoing scientific refinement. Patients receive care from an experienced medical team using advanced mesenchymal stem cell–based protocols developed to support safety, consistency, and therapeutic precision. The treatment experience is delivered in a modern medical environment designed to prioritize clinical excellence and patient care.
NovaCell in Barranquilla is part of an evolving field in regenerative medicine focused on clinical application, patient care, and ongoing scientific advancement.
Our medical team is committed to prioritizing patient safety, well-being, and treatment quality through advanced stem cell–based protocols delivered in a professional clinical environment.
To learn more about our regenerative medicine programs, start HERE.
Dr. Martha Liliana Cuellar Herrera, M.D. Staff Physician Dr. Cuellar Herrera is a medical physician focused on patient-centered care and regenerative medicine applications. She earned her medical degree in 2017 and has experience in clinical practice and supportive therapies aimed at improving patient wellbeing and quality of life.
NovaCell Regenerative Medicine by Belleza
Cra 59B 81-143
Barranquilla, Colombia
Outside or Inside US Call:
Phone: +1 (754) 333-6754
Copyright 2026, NovaCell Institute in Barranquilla, Colombia. All rights reserved.